BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lutz H, Hu S, Dinh P, Cheng K. Cells and cell derivatives as drug carriers for targeted delivery. Medicine in Drug Discovery 2019;3:100014. [DOI: 10.1016/j.medidd.2020.100014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 4.7] [Reference Citation Analysis]
Number Citing Articles
1 Podsiedlik M, Markowicz-Piasecka M, Sikora J. Erythrocytes as model cells for biocompatibility assessment, cytotoxicity screening of xenobiotics and drug delivery. Chem Biol Interact 2020;332:109305. [PMID: 33130048 DOI: 10.1016/j.cbi.2020.109305] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 García-álvarez R, Vallet-regí M. Bacteria and cells as alternative nano-carriers for biomedical applications. Expert Opinion on Drug Delivery. [DOI: 10.1080/17425247.2022.2029844] [Reference Citation Analysis]
3 Oroojalian F, Beygi M, Baradaran B, Mokhtarzadeh A, Shahbazi MA. Immune Cell Membrane-Coated Biomimetic Nanoparticles for Targeted Cancer Therapy. Small 2021;17:e2006484. [PMID: 33577127 DOI: 10.1002/smll.202006484] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
4 Grigoletto A, Tedeschini T, Canato E, Pasut G. The evolution of polymer conjugation and drug targeting for the delivery of proteins and bioactive molecules. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;13:e1689. [PMID: 33314717 DOI: 10.1002/wnan.1689] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Mirkhani N, Gwisai T, Schuerle S. Engineering Cell‐Based Systems for Smart Cancer Therapy. Advanced Intelligent Systems 2022;4:2100134. [DOI: 10.1002/aisy.202100134] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]